Black Diamond Therapeutics Stock Price To Earning
| BDTX Stock | USD 2.83 0.24 9.27% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Black Diamond's long-term financial health and intrinsic value.
Black | Price To Earning | Build AI portfolio with Black Stock |
Black Diamond Therapeutics Company Price To Earning Analysis
Black Diamond's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Black Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Black Diamond is extremely important. It helps to project a fair market value of Black Stock properly, considering its historical fundamentals such as Price To Earning. Since Black Diamond's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Black Diamond's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Black Diamond's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Black Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Black Diamond Therapeutics has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Black Diamond Current Valuation Drivers
We derive many important indicators used in calculating different scores of Black Diamond from analyzing Black Diamond's financial statements. These drivers represent accounts that assess Black Diamond's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Black Diamond's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 1.1B | 192.9M | 65.4M | 117.8M | 135.4M | 128.7M | |
| Enterprise Value | 1.0B | 155.5M | 59.2M | 103.5M | 119.0M | 113.1M |
Black Diamond ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Black Diamond's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Black Diamond's managers, analysts, and investors.Environmental | Governance | Social |
Black Fundamentals
| Return On Equity | 0.0414 | ||||
| Return On Asset | -0.0042 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.78 % | ||||
| Current Valuation | 16.46 M | ||||
| Shares Outstanding | 56.86 M | ||||
| Shares Owned By Insiders | 0.62 % | ||||
| Shares Owned By Institutions | 83.40 % | ||||
| Number Of Shares Shorted | 6.06 M | ||||
| Price To Book | 1.04 X | ||||
| Price To Sales | 2.10 X | ||||
| Gross Profit | 70 M | ||||
| EBITDA | (69.33 M) | ||||
| Net Income | (69.68 M) | ||||
| Cash And Equivalents | 160.89 M | ||||
| Cash Per Share | 4.43 X | ||||
| Total Debt | 22.19 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 8.55 X | ||||
| Book Value Per Share | 2.50 X | ||||
| Cash Flow From Operations | (62.3 M) | ||||
| Short Ratio | 4.83 X | ||||
| Earnings Per Share | 0.06 X | ||||
| Target Price | 10.75 | ||||
| Number Of Employees | 24 | ||||
| Beta | 2.72 | ||||
| Market Capitalization | 147.27 M | ||||
| Total Asset | 122.64 M | ||||
| Retained Earnings | (487.11 M) | ||||
| Working Capital | 80.6 M | ||||
| Current Asset | 123.51 M | ||||
| Current Liabilities | 4.43 M | ||||
| Net Asset | 122.64 M |
About Black Diamond Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Black Diamond Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Black Diamond using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Black Diamond Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Black Stock Analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.